Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Botulinum toxin type F useful in type A-resistant patients with dystonia

Oct. 23, 1998

Efficacy and safety demonstrated for rasagiline as adjunct to levodopa in PD

Oct. 23, 1998

New compounds from Astra for pain, GI disorders and spinal injuries

Oct. 23, 1998

Potent GABA-B antagonists described for CNS disorders by Novartis

Oct. 23, 1998

Xenotransplanted human dopaminergic cells improve motor deficits in MPTP-treated monkeys

Oct. 23, 1998

Role of neuromelanin in neuronal damage

Oct. 22, 1998

Ondansetron effective and safe in controlling TD and psychotic symptoms

Oct. 22, 1998

New treatment for AD now marketed in Germany

Oct. 22, 1998

Delta-opioid agonists considered to have potential for improving PD symptoms

Oct. 22, 1998

SIB-1508Y exerts neuroprotective effects in addition to beneficial motor/cognitive actions

Oct. 22, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 24, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...